These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 9312189)

  • 21. Sequential expression of genes involved in muscular dystrophies during human development.
    Durand M; Suel L; Barbet JP; Beckmann JS; Fougerousse F
    Morphologie; 2002 Jun; 86(273):9-12. PubMed ID: 12224393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Merosin and congenital muscular dystrophy.
    Miyagoe-Suzuki Y; Nakagawa M; Takeda S
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):181-91. PubMed ID: 10679965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly efficient in vivo delivery of PMO into regenerating myotubes and rescue in laminin-α2 chain-null congenital muscular dystrophy mice.
    Aoki Y; Nagata T; Yokota T; Nakamura A; Wood MJ; Partridge T; Takeda S
    Hum Mol Genet; 2013 Dec; 22(24):4914-28. PubMed ID: 23882132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative freeze-fracture study of plasma membrane of dystrophic skeletal muscles in dy/dy mice with merosin (laminin 2) deficiency and mdx mice with dystrophin deficiency.
    Shibuya S; Wakayama Y; Oniki H; Kojima H; Saito M; Etou T; Nonaka I
    Neuropathol Appl Neurobiol; 1997 Apr; 23(2):123-31. PubMed ID: 9160897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cib2 binds integrin alpha7Bbeta1D and is reduced in laminin alpha2 chain-deficient muscular dystrophy.
    Häger M; Bigotti MG; Meszaros R; Carmignac V; Holmberg J; Allamand V; Akerlund M; Kalamajski S; Brancaccio A; Mayer U; Durbeej M
    J Biol Chem; 2008 Sep; 283(36):24760-9. PubMed ID: 18611855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Muscular dystrophies due to alterations at extracellular space level: congenital muscular dystrophy caused by merosin deficiency].
    Smeyers P
    Rev Neurol; 1999 Jan 16-31; 28(2):141-9. PubMed ID: 10101782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Animal models of muscular dystrophies.
    Nonaka I
    Lab Anim Sci; 1998 Feb; 48(1):8-17. PubMed ID: 9517883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha7beta1 integrin does not alleviate disease in a mouse model of limb girdle muscular dystrophy type 2F.
    Milner DJ; Kaufman SJ
    Am J Pathol; 2007 Feb; 170(2):609-19. PubMed ID: 17255329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of merosin (laminin 2) with very late activation antigen-6 is necessary for the survival of CD4+ CD8+ immature thymocytes.
    Iwao M; Fukada S; Harada T; Tsujikawa K; Yagita H; Hiramine C; Miyagoe Y; Takeda S; Yamamoto H
    Immunology; 2000 Apr; 99(4):481-8. PubMed ID: 10792494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exon Skipping Using Antisense Oligonucleotides for Laminin-Alpha2-Deficient Muscular Dystrophy.
    Hara Y; Mizobe Y; Miyatake S; Takizawa H; Nagata T; Yokota T; Takeda S; Aoki Y
    Methods Mol Biol; 2018; 1828():553-564. PubMed ID: 30171567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The childhood muscular dystrophies: making order out of chaos.
    Tsao CY; Mendell JR
    Semin Neurol; 1999; 19(1):9-23. PubMed ID: 10711985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombospondin-4 deletion does not exacerbate muscular dystrophy in β-sarcoglycan-deficient and laminin α2 chain-deficient mice.
    Zarén P; Gawlik KI
    Sci Rep; 2024 Jun; 14(1):14757. PubMed ID: 38926599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Merosin-deficient congenital muscular dystrophy type 1A.
    Buteică E; Roşulescu E; Burada F; Stănoiu B; Zăvăleanu M
    Rom J Morphol Embryol; 2008; 49(2):229-33. PubMed ID: 18516331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sarcospan integration into laminin-binding adhesion complexes that ameliorate muscular dystrophy requires utrophin and α7 integrin.
    Marshall JL; Oh J; Chou E; Lee JA; Holmberg J; Burkin DJ; Crosbie-Watson RH
    Hum Mol Genet; 2015 Apr; 24(7):2011-22. PubMed ID: 25504048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin alpha2-deficient mice.
    Connolly AM; Keeling RM; Mehta S; Pestronk A; Sanes JR
    Neuromuscul Disord; 2001 Nov; 11(8):703-12. PubMed ID: 11595512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Massive muscle cell degeneration in the early stage of merosin-deficient congenital muscular dystrophy.
    Hayashi YK; Tezak Z; Momoi T; Nonaka I; Garcia CA; Hoffman EP; Arahata K
    Neuromuscul Disord; 2001 May; 11(4):350-9. PubMed ID: 11369186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-localization and molecular association of dystrophin with laminin at the surface of mouse and human myotubes.
    Dickson G; Azad A; Morris GE; Simon H; Noursadeghi M; Walsh FS
    J Cell Sci; 1992 Dec; 103 ( Pt 4)():1223-33. PubMed ID: 1283164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of laminin chains in skin in merosin-deficient congenital muscular dystrophy.
    Sewry CA; D'Alessandro M; Wilson LA; Sorokin LM; Naom I; Bruno S; Ferlini A; Dubowitz V; Muntoni F
    Neuropediatrics; 1997 Aug; 28(4):217-22. PubMed ID: 9309712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption.
    Straub V; Rafael JA; Chamberlain JS; Campbell KP
    J Cell Biol; 1997 Oct; 139(2):375-85. PubMed ID: 9334342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital muscular dystrophy with merosin deficiency.
    Tomé FM; Evangelista T; Leclerc A; Sunada Y; Manole E; Estournet B; Barois A; Campbell KP; Fardeau M
    C R Acad Sci III; 1994 Apr; 317(4):351-7. PubMed ID: 8000914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.